Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...